Deutsche Bank
JAZZ icon

Deutsche Bank’s Jazz Pharmaceuticals JAZZ Stock Holding History

Deutsche Bank’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-76
Closed -$9K – 4986
2016
Q3 		$9K Hold
76
– – ﹤0.01% 4683
2016
Q2 		$10K Buy
+76
New +$11.2K ﹤0.01% 4907
2016
Q1 		– Sell
-76
Closed -$10K – 5242
2015
Q4 		$10K Buy
+76
New +$10.5K ﹤0.01% 4921

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Deutsche Bank's JAZZ Position: Q2 2026 in Review

Deutsche Bank reduced its Jazz Pharmaceuticals (JAZZ) stake by 4.7% in Q2 2026, selling an estimated $260K and leaving 24,088 shares worth $5.8M. The position accounts for ﹤0.01% of the portfolio, ranked #1292.

Deutsche Bank first reported a position in JAZZ in Q2 2013 and has held it in 53 quarters since. The position peaked at $58M in Q2 2016. 646 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Deutsche Bank held 24,088 shares of Jazz Pharmaceuticals worth $5.8M as of Q2 2026.
  • Deutsche Bank sold 1,185 Jazz Pharmaceuticals shares in Q2 2026, an estimated $260K.
  • Jazz Pharmaceuticals made up ﹤0.01% of Deutsche Bank's portfolio in Q2 2026, its #1292 holding.
  • Deutsche Bank first reported a position in Jazz Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
  • Deutsche Bank's Jazz Pharmaceuticals position peaked at $58M in Q2 2016.
  • 646 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.